Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 HKD | 0.00% | 0.00% | +11.43% |
Mar. 26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
Mar. 25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
Sales 2022 | 1.28B 177M 1.38B | Sales 2023 | 1.15B 159M 1.24B | Capitalization | 1.43B 198M 1.55B |
---|---|---|---|---|---|
Net income 2022 | 358M 49.46M 387M | Net income 2023 | 326M 45.03M 353M | EV / Sales 2022 | 0.54 x |
Net cash position 2022 | 1.07B 148M 1.16B | Net cash position 2023 | 1.05B 145M 1.14B | EV / Sales 2023 | 0.33 x |
P/E ratio 2022 |
4.93
x | P/E ratio 2023 |
4.4
x | Employees | 1,143 |
Yield 2022 |
6.63% | Yield 2023 |
7.61% | Free-Float | 39.97% |
1 month | -11.36% | ||
3 months | +7.34% | ||
6 months | +10.38% | ||
Current year | +11.43% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 22-02-15 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 02-11-30 |
Kei Ling Li
CHM | Chairman | 75 | 02-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 02-09-30 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 02-09-30 |
Hong Man Leung
BRD | Director/Board Member | 49 | 05-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.17 | 0.00% | 0 |
24-04-24 | 1.17 | -1.68% | 144,000 |
24-04-23 | 1.19 | +2.59% | 112,000 |
24-04-22 | 1.16 | +0.87% | 12,000 |
24-04-19 | 1.15 | -0.86% | 0 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+11.43% | 224M | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- 2348 Stock